N
Neurescue
Developing cardiovascular devices to help emergency patients
About Neurescue
NEURESCUE is a pioneering medical device startup that has developed the first computer-aided aortic occlusion catheter. This innovative device is designed to assist in emergency medical situations, specifically during non-traumatic cardiac arrest. The primary function of the NEURESCUE device is to temporarily block the aorta, the main artery in the body, to increase blood flow to the heart and brain during cardiopulmonary resuscitation (CPR). This process, known as Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA), can significantly improve the chances of resuscitation and protect the brain from damage due to lack of blood flow.
Read full description
NEURESCUE operates in the emergency medical market, targeting hospitals, emergency medical services (EMS), and other healthcare providers who deal with cardiac arrest cases. The device is particularly useful for emergency room doctors, paramedics, and other first responders who need to act quickly to save lives.
The business model of NEURESCUE revolves around the sale of its proprietary medical device to healthcare institutions. The company generates revenue through direct sales of the NEURESCUE device, as well as potential recurring revenue from the sale of disposable components and maintenance services. By providing a life-saving tool that is easy to use and highly effective, NEURESCUE aims to establish itself as a critical player in the emergency medical equipment market.
In summary, NEURESCUE is a medical device company that offers a groundbreaking solution for improving outcomes in cardiac arrest cases. By increasing blood flow to vital organs during CPR, the NEURESCUE device enhances the chances of patient survival and recovery. The company serves healthcare providers in the emergency medical field and generates revenue through the sale of its innovative device and related services.
At a glance
- Founded
- 2014
- Headquarters
- Copenhagen, Denmark
- Sector
- Biotech & Life Sciences
Latest news
Press, funding announcements and product moves mentioning Neurescue.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
European Innovation Council
Series A1 investor entered at this stage
West Hill Capital
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Neurescue on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Neurescue on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.